Lactecon (Lactulose)

Lactulose is not absorbed in the small intestine; in the colon it is fermented by bacteria into short‑chain acids. This acidifies the lumen, draws water into the bowel to soften stools, and converts ammonia to ammonium, which is less readily absorbed, thereby lowering systemic ammonia.

The dose of Lactecon is individualized by the prescribing clinician based on the patient’s condition, severity, and response. Healthcare professionals determine the appropriate amount and frequency according to clinical guidelines and patient needs.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Lactecon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactecon (lactulose) is an osmotic laxative that works by increasing colonic water content, whereas stimulant laxatives such as bisacodyl act by stimulating intestinal motility. Lactulose also lowers blood ammonia, a benefit not shared by most other laxatives, making it the preferred choice for hepatic encephalopathy.

Lactecon should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency.

Lactecon is taken orally, typically as a liquid solution. The patient should swallow the measured dose directly or mix it with a small amount of water or juice, following the instructions provided by the prescriber.

Serious risks, though uncommon, include severe electrolyte imbalance, dehydration, allergic reactions, and, in rare cases, colonic perforation. Patients should seek immediate medical attention if they experience extreme abdominal pain, persistent vomiting, or signs of an allergic response.

Lactecon is contraindicated in patients with known hypersensitivity to lactulose, complete intestinal obstruction, or severe inflammatory bowel disease. Caution is also advised for individuals with renal impairment, uncontrolled diabetes, or those taking medications that may interact significantly.